144 related articles for article (PubMed ID: 20610991)
1. Imaging of compensatory mechanisms in Parkinson's disease.
Appel-Cresswell S; de la Fuente-Fernandez R; Galley S; McKeown MJ
Curr Opin Neurol; 2010 Aug; 23(4):407-12. PubMed ID: 20610991
[TBL] [Abstract][Full Text] [Related]
2. Joint amplitude and connectivity compensatory mechanisms in Parkinson's disease.
Palmer SJ; Li J; Wang ZJ; McKeown MJ
Neuroscience; 2010 Apr; 166(4):1110-8. PubMed ID: 20074617
[TBL] [Abstract][Full Text] [Related]
3. Contributions of functional imaging to understanding parkinsonian symptoms.
Grafton ST
Curr Opin Neurobiol; 2004 Dec; 14(6):715-9. PubMed ID: 15582373
[TBL] [Abstract][Full Text] [Related]
4. Cortico-basal ganglia and cortico-cerebellar circuits in Parkinson's disease: pathophysiology or compensation?
Martinu K; Monchi O
Behav Neurosci; 2013 Apr; 127(2):222-36. PubMed ID: 23244290
[TBL] [Abstract][Full Text] [Related]
5. Plasticity of the nigropallidal pathway in Parkinson's disease.
Whone AL; Moore RY; Piccini PP; Brooks DJ
Ann Neurol; 2003 Feb; 53(2):206-13. PubMed ID: 12557287
[TBL] [Abstract][Full Text] [Related]
6. Increased cerebral activity in Parkinson's disease patients carrying the DRD2 TaqIA A1 allele during a demanding motor task: a compensatory mechanism?
Bartrés-Faz D; Martí MJ; Junqué C; Solé-Padullés C; Ezquerra M; Bralten LB; Gaig C; Campdelacreu J; Mercader JM; Tolosa E
Genes Brain Behav; 2007 Aug; 6(6):588-92. PubMed ID: 17147698
[TBL] [Abstract][Full Text] [Related]
7. Dopamine depletion alters macroscopic network dynamics in Parkinson's disease.
Shine JM; Bell PT; Matar E; Poldrack RA; Lewis SJG; Halliday GM; O'Callaghan C
Brain; 2019 Apr; 142(4):1024-1034. PubMed ID: 30887035
[TBL] [Abstract][Full Text] [Related]
8. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
Kish SJ
Adv Neurol; 2003; 91():39-49. PubMed ID: 12442662
[No Abstract] [Full Text] [Related]
9. Stage-dependent patterns of disturbed neural synchrony in Parkinson's disease.
Berendse HW; Stam CJ
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S440-5. PubMed ID: 18267280
[TBL] [Abstract][Full Text] [Related]
10. Nondopaminergic neurons in Parkinson's disease.
Hirsch EC; Orieux G; Muriel MP; Francois C; Feger J
Adv Neurol; 2003; 91():29-37. PubMed ID: 12449099
[No Abstract] [Full Text] [Related]
11. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease.
Strange PG
Mov Disord; 1993 Jul; 8(3):263-70. PubMed ID: 8101967
[TBL] [Abstract][Full Text] [Related]
12. Dopamine influences primary motor cortex plasticity and dorsal premotor-to-motor connectivity in Parkinson's disease.
Suppa A; Iezzi E; Conte A; Belvisi D; Marsili L; Modugno N; Fabbrini G; Berardelli A
Cereb Cortex; 2010 Sep; 20(9):2224-33. PubMed ID: 20051362
[TBL] [Abstract][Full Text] [Related]
13. Dysfunctional and compensatory synaptic plasticity in Parkinson's disease.
Schroll H; Vitay J; Hamker FH
Eur J Neurosci; 2014 Feb; 39(4):688-702. PubMed ID: 24313650
[TBL] [Abstract][Full Text] [Related]
14. Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
Anglade P; Tsuji S; Javoy-Agid F; Agid Y; Hirsch EC
Ann Neurol; 1995 Feb; 37(2):265-72. PubMed ID: 7847868
[TBL] [Abstract][Full Text] [Related]
15. Motor sequence learning and movement disorders.
Doyon J
Curr Opin Neurol; 2008 Aug; 21(4):478-83. PubMed ID: 18607210
[TBL] [Abstract][Full Text] [Related]
16. Functional imaging of cognition in Parkinson's disease.
Carbon M; Marié RM
Curr Opin Neurol; 2003 Aug; 16(4):475-80. PubMed ID: 12869806
[TBL] [Abstract][Full Text] [Related]
17. Cellular principles underlying normal and pathological activity in the subthalamic nucleus.
Bevan MD; Atherton JF; Baufreton J
Curr Opin Neurobiol; 2006 Dec; 16(6):621-8. PubMed ID: 17084618
[TBL] [Abstract][Full Text] [Related]
18. Basal ganglia oscillations and pathophysiology of movement disorders.
Rivlin-Etzion M; Marmor O; Heimer G; Raz A; Nini A; Bergman H
Curr Opin Neurobiol; 2006 Dec; 16(6):629-37. PubMed ID: 17084615
[TBL] [Abstract][Full Text] [Related]
19. [Neurobiologic and pharmacologic studies on the pathogenesis of Parkinson disease].
Brücke T; Riederer P
Wien Med Wochenschr; 1986 Aug; 136(15-16):401-8. PubMed ID: 2878540
[TBL] [Abstract][Full Text] [Related]
20. Synaptic dysfunction in Parkinson's disease.
Bagetta V; Ghiglieri V; Sgobio C; Calabresi P; Picconi B
Biochem Soc Trans; 2010 Apr; 38(2):493-7. PubMed ID: 20298209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
